Sotera Health Announces Secondary Offering of Common Stock

CLEVELAND, Sept. 4, 2024 (GLOBE NEWSWIRE) — Sotera Health Company (Nasdaq: SHC) (the “Company”) today announced the launch of a secondary offering (the “Offering”) of 25,000,000 shares of its common stock, par value $0.01 per share. All 25,000,000 shares are being offered for sale by certain affiliates of Warburg Pincus LLC (“Warburg Pincus”) and GTCR LLC (“GTCR”) as selling stockholders. No other entities or individuals are selling shares in the Offering. It is expected that as a result of the Offering, the Company’s sponsors (affiliates of Warburg Pincus and GTCR) will no longer own a majority of the Company’s outstanding common stock, which will affect certain sponsorship rights and related matters. These rights are described in the most recently filed proxy statement for the Company’s annual general meeting. The Company is not offering any shares in the Offering and will not receive any proceeds from the Offering. The Company will pay the expenses of the Offering in accordance with its obligations under its Amended and Restated Registration Rights Agreement.

Citigroup is acting as underwriter for the offering. The underwriter will offer the shares from time to time in one or more transactions on the Nasdaq, in the over-the-counter market or in negotiated transactions at market prices or at negotiated prices.